Hormone therapy for women with migraine

Migraine, including migraine with aura, is usually not an absolute reason to avoid hormone therapy during menopause. It does call for an individual assessment by a doctor and a deliberate choice of how the hormones are delivered. In practice we prefer transdermal estradiol, a low-dose patch or gel, because it avoids the liver passage and gives a steady level instead of peaks and dips. The familiar warning that estrogen raises stroke risk in migraine with aura comes mainly from research on the combined contraceptive pill, not from research on menopausal hormone therapy.

In short

• Migraine, including with aura, is usually not an absolute contraindication to menopausal hormone therapy, but it does require an individual assessment by a doctor.
• The strict link between aura and estrogen comes mainly from the contraceptive pill with high doses of synthetic ethinylestradiol, not from the low doses of bodily-identical estradiol used in hormone therapy.
• Transdermal estradiol (patch or gel) is preferred with migraine: it avoids the first liver passage and gives a stable level, which can reduce fluctuations as an attack trigger.
• Migraine often changes during menopause. Fluctuating levels can worsen attacks, while a stable low level after menopause reduces attacks in some women. This differs from person to person.
• Always discuss your aura status and your migraine history explicitly with your doctor before you start.

Can you use hormone therapy if you have migraine?

In most cases you can, as long as it happens under a doctor's guidance. Migraine is common in women during perimenopause, and a history of migraine does not automatically rule out hormone therapy. What matters is a careful assessment: whether you have aura, what your attack pattern looks like, which other risk factors play a role, and which menopausal complaints you want to treat.

The choice depends less on whether you may use estrogen, and more on the form and the dose. A low, steady dose through the skin is a different story from a high oral dose. We explain that distinction below.

Why does the difference between the pill and hormone therapy matter?

The warning many women know, that you should not use estrogen with migraine with aura, is about the combined contraceptive pill. That pill contains synthetic ethinylestradiol in a relatively high dose, and in migraine with aura this is linked to a higher risk of stroke. The World Health Organization therefore advises against the combined pill in women over 35 who have migraine with aura (American Headache Society).

Menopausal hormone therapy is a different category. It uses bodily-identical estradiol in a much lower dose, often through the skin. Researchers point out that the aura risk seen with the contraceptive pill cannot simply be transferred to these low, physiological doses. The risk does not disappear on its own, but it sits in a different order of magnitude.

Why is transdermal estradiol preferred with migraine?

Oral estrogen passes through the liver first. There it influences the production of clotting factors, which can slightly raise the risk of vascular complications. Transdermal estradiol, through a patch or gel, largely bypasses that first liver passage and therefore has less effect on clotting. Guidelines accordingly advise the transdermal route in women with a raised vascular risk (NICE NG23).

For migraine there is something else at play: a patch or gel gives a steady level, while tablets give more fluctuation. It is exactly those fluctuations, and especially the drop in estrogen, that act as an attack trigger in many women. A stable, low dose can help reduce that trigger (MacGregor, 2018).

What does migraine with aura mean for the choice?

Migraine with aura carries a slightly higher baseline risk of stroke, even without hormones. That is the reason for the caution with estrogen. With menopausal hormone therapy using a low, transdermal dose of bodily-identical estradiol, aura is not an absolute contraindication, unlike with the contraceptive pill containing ethinylestradiol (Expert Review of Neurotherapeutics, 2024).

The practical line doctors often follow: use the lowest effective dose that brings your menopausal complaints under control, choose the transdermal route, and discuss your aura status explicitly. If the aura increases in frequency or changes in character after you start, that is a reason to review the treatment, not to continue without consultation.

Wondering how hormones and your migraine interact? Our free guide explains a broader view of menopause and can help you prepare the conversation with your doctor. Download the free guide →

Does migraine change during menopause?

Often it does. In perimenopause the estrogen levels move erratically, and those fluctuations can temporarily worsen migraine, especially migraine without aura that is linked to menstruation. After menopause, when the levels stay low but stable, the attacks decrease in some women. This differs greatly from person to person and cannot be predicted in advance.

That is why hormone therapy with migraine is not about avoiding estrogen, but about avoiding fluctuations. A steady, low dose aims to smooth out the swings that many women experience as a trigger.

How does Menovia approach this?

At Menovia we include migraine and aura as standard in the intake, precisely because some of the women who come to us already have a migraine diagnosis. We work with bio-identical, bodily-identical hormones and, with migraine, prefer transdermal estradiol in a tailored dose. If the uterus is present, micronized bio-identical progesterone belongs with it to protect the uterine lining.

We match the dose to your blood values and your pattern of complaints, with blood tests every twelve weeks and a monthly consultation with a doctor. That way we see not only what your blood values do, but also how you feel. If you want to know what to look for when choosing a clinic, read what to look for in a menopause clinic, and more about bio-identical hormones.

When to see a doctor

Migraine is usually harmless, but some signs should be assessed quickly. Contact your doctor or, with sudden loss of function, emergency care if you recognize any of the following:

• Aura for the first time, or an aura that is clearly different from what you are used to, certainly if you use estrogen.
• An aura that lasts longer than an hour, or neurological complaints such as loss of strength, speech or vision that do not resolve on their own.
• A sudden, very severe headache that reaches its peak within seconds to minutes.
• A clear increase in attacks or aura shortly after you started hormone therapy.

With signs of a stroke, such as a drooping face, unclear speech or weakness in one arm, call emergency services immediately. If you are unsure whether your aura status stands in the way of hormone therapy, put that question to a doctor before you change anything yourself.

Frequently asked questions

Can hormone therapy worsen my migraine? In some women, swings in the estrogen level can temporarily influence attacks. A stable, transdermal dose is aimed precisely at reducing those swings. If migraine increases after you start, discuss a dose adjustment rather than stopping straight away.

Can I use hormone therapy with migraine with aura? Usually yes, provided it is under guidance and with the lowest effective transdermal dose. At low doses of bodily-identical estradiol, aura is not an absolute contraindication, unlike with the contraceptive pill. Always discuss your aura status explicitly with your doctor.

Which form of delivery is preferred with migraine? Transdermal estradiol, through a patch or gel, is generally preferred over tablets. It avoids the liver passage and gives a steadier level, which reduces the chance of fluctuations acting as a trigger.

Does migraine decrease after menopause? In some women it does, once the estrogen level stays low but stable. It is not certain, because migraine has several triggers, including lack of sleep. Sleep problems in menopause therefore deserve their own attention, as we discuss in our article on sleep problems in menopause.

Is hormone therapy for migraine reimbursed? Part of the consultation costs may be reimbursed through supplementary insurance, depending on your policy and insurer. Registered bio-identical hormones through your own pharmacy are largely reimbursed, while custom-compounded medication usually is not.

Sources

• National Institute for Health and Care Excellence (NICE). Menopause: identification and management (NG23). nice.org.uk.
• MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reproductive Health, 2018. journals.sagepub.com.
• Considerations for hormonal therapy in migraine patients: a critical review of current practice. Expert Review of Neurotherapeutics, 2024. tandfonline.com.
• American Headache Society. Migraine and Contraceptives. americanheadachesociety.org.

This information is intended as an educational resource and does not replace medical advice, diagnosis, or treatment. For complaints or questions about your personal situation, we recommend consulting a doctor.